Question Title

* 1. How many years have you been in practice?

Question Title

* 2. How many patients with ES-SCLC do you manage per week?

Question Title

* 3. Please select the option that best describes your practice setting.

Question Title

* 4. After participating in this activity, how confident are you in the management of patients with ES-SCLC in your practice? 

Question Title

* 5. How committed are you to making changes in your practice based on your participation in this activity?

Question Title

* 6. Which of the following best describes the impact of this activity on your performance?

Question Title

* 7. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Question Title

* 8. What barriers do you see to making changes in your practice? Please select all that apply.  

Question Title

* 9. Please rate your level of agreement by checking the appropriate rating.

After participating in today’s activity, I am now better able to:

  Strongly agree Agree Neutral Disagree Strongly disagree
Compare efficacy and safety data for new and emerging treatments for second-line extensive-stage-SCLC (ES-SCLC), as well for immunotherapies approved in subsequent lines
Develop a plan of action for selecting appropriate treatment options for ES-SCLC patients who evidence disease progression during or after first-line chemotherapy

Question Title

* 10. Please rate your level of agreement by checking the appropriate rating.

Narjust Duma, MD, effectively:

  Strongly agree Agree Neutral Disagree Strongly disagree
Presented the Material
Avoided Commercial Bias

Question Title

* 11. Please rate your level of agreement by checking the appropriate rating.

Jacob M. Sands, MD, effectively:

  Strongly agree Agree Neutral Disagree Strongly disagree
Presented the Material
Avoided Commercial Bias

Question Title

* 12. The content presented:  

  Strongly agree Agree Neutral Disagree Strongly disagree
Enhanced my current knowledge base
Addressed my most pressing questions
Promoted improvements or quality in health care
Was scientifically rigorous and evidence based
Avoided commercial bias or influence

Question Title

* 13. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 14. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for ES-SCLC:

Question Title

* 15. If you indicated that you perceived commercial bias or influence, please describe:

T